The use of angiotensin-converting enzyme inhibitors, β-blockers, spironolactone and other drugs is restricted or even discontinued in patients with chronic HF due to increased creatinine levels, renal dysfunction and other reasons. This evidence concerns the gene ACE and Abnormal renal physiology.